RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: myelitis
Accession: DOID:322
browse the term
Definition: A spinal cord disease that is characterized by inflammation of the white matter or gray matter of the spinal cord. (DO)
Synonyms: exact_synonym: Infectious Myelitis; Inflammatory Myelopathy; Myelitides; Spinal Cord Inflammation; Spinal Cord Inflammations; inflammatory myelopathies; subacute necrotising myelitis
primary_id: MESH:D009187
xref: EFO:1001472 ; GARD:7130 ; NCI:C26832
For additional species annotation, visit the
Alliance of Genome Resources .
G
CACNA1A
calcium voltage-gated channel subunit alpha1 A
IAGP
ClinVar Annotator: match by term: Myelitis
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532
NCBI chr19:13,206,442...13,506,479
Ensembl chr19:13,206,442...13,624,489
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
susceptibility
IAGP
DNA:polymorphism: :HLA-DPB1*0201 (human)
RGD
PMID:22884298
RGD:150429795
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,936...33,089,696
G
AQP4
aquaporin 4
disease_progression
IDA EXP ISO IAGP
CTD Direct Evidence: marker/mechanism associated withHiccup; DNA:polymorphism:promoter:-1003A>G(human)
CTD RGD
PMID:18509235 PMID:24070676 PMID:16087714 PMID:22271321 PMID:18420727 PMID:23116879 PMID:23890015 PMID:23995423 PMID:20047900 More...
RGD:5148024 , RGD:8696034 , RGD:8696033 , RGD:8696032 , RGD:8696026 , RGD:8695993 , RGD:5148032
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
CD59
CD59 molecule (CD59 blood group)
severity
ISO
RGD
PMID:28212662
RGD:13792592
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
G
GFAP
glial fibrillary acidic protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18509235
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP
DNA:polymorphism:cds:HLA-DQB1*0402 (human) DNA:polymorphism:: HLA-DQB1*02:02 (human)
RGD
PMID:21908482 PMID:27049564
RGD:7421588 , RGD:11530523
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility
IAGP
DNA:polymorphism (human) DNA:polymorphism:: HLA-DRB1*04:04, DRB1*07:01, DRB1*10:01(human)
RGD
PMID:21748712 PMID:27049564
RGD:5147590 , RGD:11530523
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
IL21
interleukin 21
IEP
protein:increased expression:cerebrospinal fluid (human)
RGD
PMID:23041403
RGD:127285589
NCBI chr 4:122,610,108...122,621,066
Ensembl chr 4:122,610,108...122,621,066
G
IL32
interleukin 32
exacerbates
IEP
protein:increased expression:blood plasma (human)
RGD
PMID:23180362
RGD:150340728
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
IL6
interleukin 6
severity
IEP
protein:increased expression:serum, cerebral spinal fluid:
RGD
PMID:20128675
RGD:7829722
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
MBP
myelin basic protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18509235
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
G
MMP9
matrix metallopeptidase 9
IEP
protein:increased expression:serum
RGD
PMID:21621856
RGD:8547883
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
NEFH
neurofilament heavy chain
IEP
protein:increased expression:serum:
RGD
PMID:23316360
RGD:27226805
NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390
G
NEFL
neurofilament light chain
IEP
protein:increased expression:serum (human)
RGD
PMID:33317883
RGD:127285024
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
S100B
S100 calcium binding protein B
IEP
RGD
PMID:21371524
RGD:5508767
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
PVR
PVR cell adhesion molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:3020560 PMID:28446605
NCBI chr19:44,643,910...44,666,162
Ensembl chr19:44,643,798...44,666,162
G
AQP4
aquaporin 4
IDA
RGD
PMID:21771203 PMID:23999580
RGD:5148008 , RGD:8696028
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
IL6
interleukin 6
IEP
protein:increased expression:serum, cerebral spinal fluid:
RGD
PMID:20128675
RGD:7829722
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
VPS37A
VPS37A subunit of ESCRT-I
IAGP
ClinVar Annotator: match by term: Idiopathic transverse myelitis
ClinVar
PMID:25741868 PMID:28492532 PMID:29473047
NCBI chr 8:17,246,958...17,333,455
Ensembl chr 8:17,246,931...17,302,427
G
C3
complement C3
IEP
protein:increased processing:plasma
RGD
PMID:7561187
RGD:11040775
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
IEP
mRNA:decreased expression: T cell
RGD
PMID:20945034
RGD:38549361
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CXCL8
C-X-C motif chemokine ligand 8
severity
IEP
protein:increased expression:plasma (human)
RGD
PMID:26800845
RGD:39939014
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
FOXP3
forkhead box P3
disease_progression
IEP
mRNA:decreased expression: T cell
RGD
PMID:28101786 PMID:20945034
RGD:38456004 , RGD:38549361
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP
RGD
PMID:25729550
RGD:36174012
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
IDA
RGD
PMID:11984596
RGD:10045967
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
G
IFNL1
interferon lambda 1
IEP
associated with HTLV-I Infections;mRNA:decreased expression:peripheral blood mononuclear cell (human)
RGD
PMID:29990995
RGD:126848769
NCBI chr19:39,296,407...39,298,673
Ensembl chr19:39,296,407...39,298,673
G
IL21
interleukin 21
IEP
protein:decreased expression:blood serum (human)
RGD
PMID:28378248
RGD:127285561
NCBI chr 4:122,610,108...122,621,066
Ensembl chr 4:122,610,108...122,621,066
G
IL27
interleukin 27
IEP
associated with HTLV-I Infections;mRNA:decreased expression:blood (human)
RGD
PMID:24041428
RGD:126790519
NCBI chr16:28,499,362...28,506,834
Ensembl chr16:28,499,362...28,512,051
G
KLRK1
killer cell lectin like receptor K1
susceptibility
IAGP
DNA:SNPs:3'utr, 5'utr: (rs1049174,rs12821887,rs12819494) (human)
RGD
PMID:22170554
RGD:39018559
NCBI chr12:10,372,353...10,390,041
Ensembl chr12:10,372,353...10,391,874
G
MMP2
matrix metallopeptidase 2
IEP
associated with Sjogren's Syndrome
RGD
PMID:10464559
RGD:8657078
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
NFKB1
nuclear factor kappa B subunit 1
susceptibility
IAGP
DNA:SNP:5'utr: (rs3138045) (human)
RGD
PMID:22170554
RGD:39018559
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
TNFRSF18
TNF receptor superfamily member 18
disease_progression
IEP
mRNA:decreased expression: T cell
RGD
PMID:28101786 PMID:20945034
RGD:38456004 , RGD:38549361
NCBI chr 1:1,203,508...1,206,592
Ensembl chr 1:1,203,508...1,206,592
G
ZEB1
zinc finger E-box binding homeobox 1
ISS
OMIM:159580
MouseDO
NCBI chr10:31,318,417...31,529,804
Ensembl chr10:31,318,495...31,529,814
G
CRP
C-reactive protein
disease_progression
IEP
RGD
PMID:14636287
RGD:9491594
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all